Malin completes Kymab sale to Sanofi
Malin Corporation has completed the previously announced sale of its investee company Kymab to Sanofi for an upfront payment of approximately $1.1 billion and up to $350m more on the achievement of certain milestones.
Business
• 09 Apr 21
